Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06365788 |
|
Recruitment Status :
Recruiting
First Posted : April 15, 2024
Last Update Posted : April 15, 2024
|
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborators:
Kom Op Tegen Kanker
Eli Lilly and Company
Teva Pharma
Information provided by (Responsible Party):
Universitaire Ziekenhuizen KU Leuven
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2027 |
| Estimated Study Completion Date : | December 2027 |